Fig. 5From: Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerThe expression level of DDIT4 in different cancers compared with that in normal tissues in the TIMER databaseBack to article page